- Home
- DGICB vs ARCT Comparison
DGICB vs ARCT Comparison
Compare DGICB & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGICB
- ARCT
- Stock Information
- Founded
- DGICB 1986
- ARCT 2013
- Country
- DGICB United States
- ARCT United States
- Employees
- DGICB N/A
- ARCT N/A
- Industry
- DGICB Property-Casualty Insurers
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- DGICB Finance
- ARCT Health Care
- Exchange
- DGICB Nasdaq
- ARCT Nasdaq
- Market Cap
- DGICB 504.0M
- ARCT 487.0M
- IPO Year
- DGICB N/A
- ARCT N/A
- Fundamental
- Price
- DGICB $14.88
- ARCT $16.79
- Analyst Decision
- DGICB
- ARCT Strong Buy
- Analyst Count
- DGICB 0
- ARCT 7
- Target Price
- DGICB N/A
- ARCT $65.00
- AVG Volume (30 Days)
- DGICB 783.0
- ARCT 400.9K
- Earning Date
- DGICB 02-20-2025
- ARCT 03-06-2025
- Dividend Yield
- DGICB 4.17%
- ARCT N/A
- EPS Growth
- DGICB 148.60
- ARCT N/A
- EPS
- DGICB 0.74
- ARCT N/A
- Revenue
- DGICB $979,119,004.00
- ARCT $160,399,000.00
- Revenue This Year
- DGICB N/A
- ARCT $7.33
- Revenue Next Year
- DGICB $5.78
- ARCT $4.71
- P/E Ratio
- DGICB $19.93
- ARCT N/A
- Revenue Growth
- DGICB 7.44
- ARCT N/A
- 52 Week Low
- DGICB $10.75
- ARCT $14.30
- 52 Week High
- DGICB $16.81
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- DGICB 57.56
- ARCT 46.15
- Support Level
- DGICB $13.90
- ARCT $16.07
- Resistance Level
- DGICB $14.20
- ARCT $17.95
- Average True Range (ATR)
- DGICB 0.30
- ARCT 1.36
- MACD
- DGICB 0.00
- ARCT -0.07
- Stochastic Oscillator
- DGICB 63.08
- ARCT 14.86
About DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.